AI
TMO icon

AXS Investments’s Thermo Fisher Scientific TMO Stock Holding History

AXS Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
733
-163
-18% -$78.2K 0.1% 96
2026
Q1 		$440K Sell
896
-179
-17% -$97.1K 0.18% 94
2025
Q4 		$623K Sell
1,075
-116
-10% -$65.6K 0.21% 90
2025
Q3 		$578K Buy
1,191
+396
+50% +$184K 0.18% 96
2025
Q2 		$322K Sell
795
-2,827
-78% -$1.18M 0.13% 132
2025
Q1 		$1.8M Sell
3,622
-3,993
-52% -$2.16M 0.5% 55
2024
Q4 		$3.96M Buy
7,615
+1,818
+31% +$1,000K 1.1% 16
2024
Q3 		$3.59M Buy
5,797
+2,542
+78% +$1.5M 0.95% 17
2024
Q2 		$1.8M Sell
3,255
-273
-8% -$156K 0.5% 73
2024
Q1 		$2.05M Sell
3,528
-178
-5% -$99.9K 0.49% 54
2023
Q4 		$1.97M Buy
3,706
+144
+4% +$69.7K 0.47% 62
2023
Q3 		$1.8M Sell
3,562
-277
-7% -$148K 0.47% 63
2023
Q2 		$2M Buy
3,839
+195
+5% +$105K 0.53% 40
2023
Q1 		$2.1M Sell
3,644
-94
-3% -$53K 0.69% 30
2022
Q4 		$2.06M Buy
3,738
+201
+6% +$107K 0.74% 28
2022
Q3 		$1.79M Sell
3,537
-394
-10% -$220K 0.7% 31
2022
Q2 		$2.14M Buy
3,931
+1,235
+46% +$680K 0.76% 29
2022
Q1 		$1.59M Sell
2,696
-990
-27% -$569K 0.63% 41
2021
Q4 		$2.46M Buy
3,686
+2,889
+362% +$1.8M 0.58% 54
2021
Q3 		$455K Sell
797
-3,350
-81% -$1.84M 0.17% 59
2021
Q2 		$2.09M Sell
4,147
-1,211
-23% -$571K 0.64% 41
2021
Q1 		$2.44M Buy
+5,358
New +$2.56M 0.87% 35

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AXS Investments's TMO Position: Q2 2026 in Review

AXS Investments reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, selling an estimated $78.2K and leaving 733 shares worth $367K. The position accounts for 0.1% of the portfolio, ranked #96.

AXS Investments first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.96M in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • AXS Investments held 733 shares of Thermo Fisher Scientific worth $367K as of Q2 2026.
  • AXS Investments sold 163 Thermo Fisher Scientific shares in Q2 2026, an estimated $78.2K.
  • Thermo Fisher Scientific made up 0.1% of AXS Investments's portfolio in Q2 2026, its #96 holding.
  • AXS Investments first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • AXS Investments's Thermo Fisher Scientific position peaked at $3.96M in Q4 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.